Pixelgen Technologies
pixelgen.com
Actively hiring
Cell & Gene Therapy
Biotechnology
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$15.5M
2 rounds on record
Latest round
$15.5M
Series B · Aug 2026 · 1 mo ago
Team
51-200
employees, estimated range
Backers
2
Industrifonden, Navigare Ventures
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
35/100
in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 20
Raised a round Series B $15.5M · YahooFinance
Feb 24, 2025
Launched Pixelgen Technologies Unveils Nanoscale Proximity Network Assay for Analyzing Protein Interactomics of Single Cells, Launches New Product Line · PRNewswire
Oct 9, 2023
Raised a round Series A · PRNewswire
Jun 13, 2023
Launched Pixelgen Technologies Launches First Molecular Pixelation Kit For 3D Spatial Analysis Of Cell Surface Proteins · menafn
Dec 6, 2022
Launched Pixelgen Technologies Launches to Advance Single-Cell Spatial Proteomics · Nasdaq
2020
Founded
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Aug 2026 | $15.5M | — | YahooFinance |
| Series A | Oct 2023 | — | — | PRNewswire |
Backed byfrom the funds' portfolios and accelerator catalogs
Industrifonden 
Navigare Ventures Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Conception combines stem cell biology and engineering to create new possibilities for having children.
Designer cell therapies for pets first and their people next.
Benefits platform for cell and gene therapies designed to provide sustainable access to life-saving medicines.
PINPOINT DNA MEDICINES FOR CHRONIC DISEASES. Next generation precision molecular therapies to tackle, in a safe and durable way, chronic…
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
Cell Microsystems develops innovative tools that allow researchers to image, sort, and isolate single cells and colonies for use in the…
News
Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansion
Pixelgen Technologies, developer of the first high-throughput platform for mapping molecular cell architecture, today announced it has closed an oversubscribed $15.5 million (approximately SEK 150 million) Series B financing to accelerate global commercia
Read more
Report
Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansion
/PRNewswire/ -- Pixelgen Technologies, developer of the first high-throughput platform for mapping molecular cell architecture, today announced it has closed...
Read more
Report
Pixelgen Technologies Closes $15.5M Oversubscribed Series B to Accelerate Global Expansion
/PRNewswire/ -- Pixelgen Technologies, developer of the first high-throughput platform for mapping molecular cell architecture, today announced it has closed...
Read more
Report
Pixelgen Technologies and Andreas Lundqvist
Pixelgen Technologies today announced a research collaboration with Andreas Lundqvist
Read more
Report
Spatial Proteomics Firm Pixelgen Moving Into Protein-Protein Interaction, Intracellular Analyses
The Swedish firm is using a recent €12.5 million award from the European Innovation Council to drive the rollout of a new assay chemistry and move into new research areas.
Read more
Report
Pixelgen Technologies: $14.7 Million Awarded From European Innovation Council Accelerator
Pixelgen Technologies has announced that it has been awarded EUR 12.5 million ($14.7 million) in grant and equity financing from the European Innovation Council (EIC) Accelerator. This initiative (under the European Union's Horizon Europe program) looks t
Read more
Report
Life Science Firms Receive €25M-Plus in Funding From European Innovation Council
Swedish proteomics firm Pixelgen and Swedish sequencing firm Single Technologies each received €12.5 million while UK molecular diagnostics firm Mitra Bio received £530,000.
Read more
Report
Pixelgen Technologies Awarded $14.7 Million In Blended Funding From European Innovation Council Accelerator
Read more
Report
Pixelgen Technologies Unveils Nanoscale Proximity Network Assay for Analyzing Protein Interactomics of Single Cells, Launches New Product Line
/PRNewswire/ -- Pixelgen Technologies today unveiled a novel technology for exploring the dynamic protein interactome at the single cell level, building on its...
Read more
Report
Pixelgen Technologies
Research outputs, collaborations and relationships for Pixelgen Technologies
Read more
Report
Show more news